Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1994-12-14
1999-12-21
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 854, 514 2, 514 12, 514 21, 530351, A61K 3821, C07K 1400
Patent
active
060045493
ABSTRACT:
A pharmaceutical composition comprised of a crystalline protein and polyethylene glycol or vegetable oil and a process for producing the same.
REFERENCES:
patent: 5028587 (1991-07-01), Dorschug et al.
patent: 5109119 (1992-04-01), Reichert et al.
patent: 5157021 (1992-10-01), Balschmidt et al.
patent: 5403824 (1995-04-01), D'Souza et al.
patent: 5441734 (1995-08-01), Reichert et al.
Biosis Previews, 1978, Biosis No. 67068942, 27(4):11-16.
Benzon et al., 1987, Anesth. Analg. 66:553-59.
J. Anschel, 1965, Pharm. Ind., 27:781-87.
List et al., 1971, Hagers Handbuch der Pharmazeutischen Praxis, Siebenter Band, Teil A., pp. 356-357.
List et al., 1985, Arzneiformenlehre, 4. Auflage, pp. 514-518.
Hruza Alan W.
Nagabhushan Tattanahalli
Nagabushan Nagamani
Reichert Paul
Achutamurthy Ponnathapura
Dulak Norman C.
McLaughlin Jaye P.
Schering Corporation
LandOfFree
Crystalline protein controlled release compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline protein controlled release compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline protein controlled release compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-502180